ArticleTranslational pediatrics2026
Twelve-month outcomes and exploratory outcome indicators after iRoot BP Plus pulpotomy in primary molars: a retrospective real-world cohort study.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Deep caries in primary molars threatens pulpal health, and treatment choices should balance infection control with tooth retention. This retrospective cohort study described 12-month outcomes of primary molar pulpotomy using iRoot BP Plus (BP), while calcium hydroxide [Ca(OH) Methods: Children aged 3-10 years who received pulpotomy between September 2022 and January 2025 were included if baseline and treatment records were complete, with the tooth as the analytic unit. The 12-month outcome analysis was restricted to teeth with evaluable follow-up records within a 10-14-month window. Biological success was adjudicated from clinical follow-up records and available radiographs within the 10-14-month window; radiographic assessment was not available for all evaluable teeth. Restoration complications were assessed only among biologically successful teeth. Within BP-treated teeth, preoperative symptoms, hemostasis time (<1 Results: Sixty-seven children contributed 122 primary molars [BP, 81; Ca(OH) Conclusions: Among evaluable BP-treated teeth, the observed 12-month biological success proportion was 95.0% within guideline-based indications. The BP-group indicator patterns were descriptive and hypothesis-generating, and require external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.